OCT DACH Conference 2022 - Outsourcing in Clinical Trials

© GlobalData/Arena International

This is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for operational success in clinical trials. Combining OCT, CTS and Medical Devices events, this is the perfect platform for professionals from across a range of clinical trial functions to meet, network, and hear about latest developments.

OCT DACH conference is providing a specific platform for the clinical trials community in the DACH region to develop innovative clinical operations and outsourcing strategies.

Place: Holiday Inn Munich City Centre, Munich, Germany
Date: 30th November - 1st December 2022

Anyone from clinical operations, regulatory affairs, clinical data management and medical device departments is most welcome to join.

For companies of the Bavarian biotech industry BioM offers in cooperation with Global Data/Arena International 3 Free Delegate VIP Registration (a non-paid delegate pass) per company.

For a free pass code, please contact us at

•    Got to the registration website:

•    Select Pharma/Medical Device/Biotech Delegate – Complimentary Pass and enter your details

•    Insert the complimentary code into the *Reference code field and submit.

Free Delegate Pass includes access to all sessions, roundtables, lunch, refreshments, coffee, food, networking, evening drinks reception (Day-1), plus: speakers’ slides and Certificate of Attendance post-event.

Attendance: one day only, or both days / per availability.
Unfortunately BD and Marketing job titles are not allowed at our scientifically driven events.

Agenda highlights: EU Regulatory Landscape; Re-Defining Contractual Relationships; Selecting a CRO; Regulatory & Quality Strategy for Drug-Device Combination Products; Data Management Innovations; Vendor Management and Oversight; GDPR & Patient Consent; New Patient Experience Strategies; Decentralised Trials & Patient Centricity.

Full OCT DACH Agenda:
More information at: